Coherus

layoffs job cuts fired exit restructuring layoff reduction
Marketing

Coherus loses commercial chief amid exit from biosimilar space

As the biotech completes its pivot away from biosimilars, Reider has resigned as chief commercial officer to pursue other opportunities.
Nick Paul Taylor Apr 23, 2025 11:19am
merger virtual handshake

Coherus sells Neulasta biosimilar to Intas for up to $558M

Dec 3, 2024 4:16pm
shortages drugs

Coherus' Udenyca in short supply thanks to contractor flub

Sep 17, 2024 2:25pm
Liver disease

Junshi, Coherus move Loqtorzi closer to another approval

Jun 12, 2024 11:45am
Novartis Sandoz

Amid promising launch of Humira biosim, Sandoz sees 6% growth

May 7, 2024 11:17am
Layoffs

Coherus lays off 30% of employees amid new 'sharpened focus'

Mar 13, 2024 6:10pm